View Financial HealthAccentis 배당 및 자사주 매입배당 기준 점검 0/6Accentis 현재 배당금을 지급하지 않습니다.핵심 정보0%배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향0%최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updatesBuy Or Sell Opportunity • May 05Now 23% undervalued after recent price dropOver the last 90 days, the stock has fallen 7.3% to €0.025. The fair value is estimated to be €0.033, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 9.0% over the last 3 years. Earnings per share has grown by 6.9%.Reported Earnings • Apr 20Full year 2024 earnings released: EPS: €0.001 (vs €0.002 in FY 2023)Full year 2024 results: EPS: €0.001 (down from €0.002 in FY 2023). Revenue: €6.38m (down 8.6% from FY 2023). Net income: €779.0k (down 70% from FY 2023). Profit margin: 12% (down from 37% in FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 75 percentage points per year, which is a significant difference in performance.New Risk • Mar 14New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 22% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Share price has been volatile over the past 3 months (6.9% average weekly change). Large one-off items impacting financial results. Market cap is less than US$100m (€39.8m market cap, or US$43.2m).Buy Or Sell Opportunity • Dec 17Now 21% undervaluedOver the last 90 days, the stock has risen 3.6% to €0.029. The fair value is estimated to be €0.037, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 48% over the last 3 years. Earnings per share has declined by 70%.분석 기사 • Dec 14Estimating The Intrinsic Value Of Accentis N.V. (EBR:ACCB)Key Insights The projected fair value for Accentis is €0.037 based on 2 Stage Free Cash Flow to Equity With €0.029...Buy Or Sell Opportunity • Nov 22Now 23% undervalued after recent price dropOver the last 90 days, the stock has fallen 3.6% to €0.027. The fair value is estimated to be €0.035, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 48% over the last 3 years. Earnings per share has declined by 70%.New Risk • Nov 07New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Belgian stocks, typically moving 6.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (6.4% average weekly change). Earnings have declined by 22% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (€34.1m market cap, or US$36.7m).Buy Or Sell Opportunity • Nov 06Now 24% undervalued after recent price dropOver the last 90 days, the stock has fallen 10.0% to €0.027. The fair value is estimated to be €0.036, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 48% over the last 3 years. Earnings per share has declined by 70%.Buy Or Sell Opportunity • Oct 17Now 24% undervalued after recent price dropOver the last 90 days, the stock has fallen 8.5% to €0.027. The fair value is estimated to be €0.036, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 48% over the last 3 years. Earnings per share has declined by 70%.분석 기사 • Sep 07Accentis' (EBR:ACCB) Earnings Offer More Than Meets The EyeThe market seemed underwhelmed by last week's earnings announcement from Accentis N.V. ( EBR:ACCB ) despite the healthy...New Risk • Aug 28New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 26% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 22% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (5.0% average weekly change). Large one-off items impacting financial results. Market cap is less than US$100m (€34.7m market cap, or US$38.6m).New Risk • Aug 15New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Belgian stocks, typically moving 4.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 13% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (4.7% average weekly change). Market cap is less than US$100m (€37.3m market cap, or US$40.9m).Board Change • Jun 11Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Axelle Vanthournout was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Feb 29Full year 2023 earnings released: EPS: €0.002 (vs €0 in FY 2022)Full year 2023 results: EPS: €0.002 (up from €0 in FY 2022). Revenue: €7.02m (down 7.5% from FY 2022). Net income: €2.60m (up €2.26m from FY 2022). Profit margin: 37% (up from 4.5% in FY 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings.New Risk • Aug 30New major risk - Revenue and earnings growthEarnings have declined by 4.1% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Dividend per share is over 14x earnings per share. Cash payout ratio: 377% Earnings have declined by 4.1% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (6.1% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (11% net profit margin). Market cap is less than US$100m (€34.9m market cap, or US$38.1m).New Risk • Aug 11New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Belgian stocks, typically moving 4.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Dividend per share is over 33x earnings per share. Cash payout ratio: 418% Minor Risks Share price has been volatile over the past 3 months (4.8% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (4.5% net profit margin). Market cap is less than US$100m (€36.6m market cap, or US$40.1m).Reported Earnings • Feb 22Full year 2022 earnings released: EPS: €0 (vs €0.013 in FY 2021)Full year 2022 results: EPS: €0 (down from €0.013 in FY 2021). Revenue: €7.59m (down 64% from FY 2021). Net income: €339.0k (down 98% from FY 2021). Profit margin: 4.5% (down from 81% in FY 2021). Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 16% per year, which means it is significantly lagging earnings.분석 기사 • Aug 31Estimating The Intrinsic Value Of Accentis N.V. (EBR:ACCB)How far off is Accentis N.V. ( EBR:ACCB ) from its intrinsic value? Using the most recent financial data, we'll take a...Board Change • May 19Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Mieke De Clercq was the last independent director to join the board, commencing their role in 2015. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Feb 24Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: €0.013 (up from €0.005 in FY 2020). Revenue: €32.9m (up 64% from FY 2020). Net income: €17.0m (up 193% from FY 2020). Profit margin: 52% (up from 29% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 17% per year whereas the company’s share price has increased by 18% per year.분석 기사 • Apr 08We Think Accentis (EBR:ACCB) Can Stay On Top Of Its DebtHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...분석 기사 • Mar 13Is Accentis N.V.'s (EBR:ACCB) Recent Stock Performance Influenced By Its Fundamentals In Any Way?Accentis' (EBR:ACCB) stock is up by a considerable 7.1% over the past month. We wonder if and what role the company's...분석 기사 • Dec 27Accentis (EBR:ACCB) Has A Somewhat Strained Balance SheetSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...분석 기사 • Dec 06A Look At The Fair Value Of Accentis N.V. (EBR:ACCB)How far off is Accentis N.V. ( EBR:ACCB ) from its intrinsic value? Using the most recent financial data, we'll take a...분석 기사 • Nov 17Is Accentis N.V.'s (EBR:ACCB) Recent Performance Tethered To Its Attractive Financial Prospects?Accentis' (EBR:ACCB) stock is up by 3.1% over the past month. Since the market usually pay for a company’s long-term...지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 ACCB 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: ACCB 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Accentis 배당 수익률 vs 시장ACCB의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (ACCB)0%시장 하위 25% (BE)2.5%시장 상위 25% (BE)6.8%업계 평균 (Real Estate)4.3%분석가 예측 (ACCB) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 ACCB 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 ACCB 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: ACCB Belgian 시장에서 주목할만한 배당금을 지급하지 않습니다.주주 현금 배당현금 흐름 범위: ACCB 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YBE 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/07/17 20:25종가2026/07/17 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Accentis N.V.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
Buy Or Sell Opportunity • May 05Now 23% undervalued after recent price dropOver the last 90 days, the stock has fallen 7.3% to €0.025. The fair value is estimated to be €0.033, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 9.0% over the last 3 years. Earnings per share has grown by 6.9%.
Reported Earnings • Apr 20Full year 2024 earnings released: EPS: €0.001 (vs €0.002 in FY 2023)Full year 2024 results: EPS: €0.001 (down from €0.002 in FY 2023). Revenue: €6.38m (down 8.6% from FY 2023). Net income: €779.0k (down 70% from FY 2023). Profit margin: 12% (down from 37% in FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 75 percentage points per year, which is a significant difference in performance.
New Risk • Mar 14New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 22% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Share price has been volatile over the past 3 months (6.9% average weekly change). Large one-off items impacting financial results. Market cap is less than US$100m (€39.8m market cap, or US$43.2m).
Buy Or Sell Opportunity • Dec 17Now 21% undervaluedOver the last 90 days, the stock has risen 3.6% to €0.029. The fair value is estimated to be €0.037, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 48% over the last 3 years. Earnings per share has declined by 70%.
분석 기사 • Dec 14Estimating The Intrinsic Value Of Accentis N.V. (EBR:ACCB)Key Insights The projected fair value for Accentis is €0.037 based on 2 Stage Free Cash Flow to Equity With €0.029...
Buy Or Sell Opportunity • Nov 22Now 23% undervalued after recent price dropOver the last 90 days, the stock has fallen 3.6% to €0.027. The fair value is estimated to be €0.035, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 48% over the last 3 years. Earnings per share has declined by 70%.
New Risk • Nov 07New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Belgian stocks, typically moving 6.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (6.4% average weekly change). Earnings have declined by 22% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (€34.1m market cap, or US$36.7m).
Buy Or Sell Opportunity • Nov 06Now 24% undervalued after recent price dropOver the last 90 days, the stock has fallen 10.0% to €0.027. The fair value is estimated to be €0.036, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 48% over the last 3 years. Earnings per share has declined by 70%.
Buy Or Sell Opportunity • Oct 17Now 24% undervalued after recent price dropOver the last 90 days, the stock has fallen 8.5% to €0.027. The fair value is estimated to be €0.036, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 48% over the last 3 years. Earnings per share has declined by 70%.
분석 기사 • Sep 07Accentis' (EBR:ACCB) Earnings Offer More Than Meets The EyeThe market seemed underwhelmed by last week's earnings announcement from Accentis N.V. ( EBR:ACCB ) despite the healthy...
New Risk • Aug 28New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 26% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 22% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (5.0% average weekly change). Large one-off items impacting financial results. Market cap is less than US$100m (€34.7m market cap, or US$38.6m).
New Risk • Aug 15New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Belgian stocks, typically moving 4.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 13% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (4.7% average weekly change). Market cap is less than US$100m (€37.3m market cap, or US$40.9m).
Board Change • Jun 11Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Axelle Vanthournout was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Feb 29Full year 2023 earnings released: EPS: €0.002 (vs €0 in FY 2022)Full year 2023 results: EPS: €0.002 (up from €0 in FY 2022). Revenue: €7.02m (down 7.5% from FY 2022). Net income: €2.60m (up €2.26m from FY 2022). Profit margin: 37% (up from 4.5% in FY 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings.
New Risk • Aug 30New major risk - Revenue and earnings growthEarnings have declined by 4.1% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Dividend per share is over 14x earnings per share. Cash payout ratio: 377% Earnings have declined by 4.1% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (6.1% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (11% net profit margin). Market cap is less than US$100m (€34.9m market cap, or US$38.1m).
New Risk • Aug 11New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Belgian stocks, typically moving 4.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Dividend per share is over 33x earnings per share. Cash payout ratio: 418% Minor Risks Share price has been volatile over the past 3 months (4.8% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (4.5% net profit margin). Market cap is less than US$100m (€36.6m market cap, or US$40.1m).
Reported Earnings • Feb 22Full year 2022 earnings released: EPS: €0 (vs €0.013 in FY 2021)Full year 2022 results: EPS: €0 (down from €0.013 in FY 2021). Revenue: €7.59m (down 64% from FY 2021). Net income: €339.0k (down 98% from FY 2021). Profit margin: 4.5% (down from 81% in FY 2021). Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 16% per year, which means it is significantly lagging earnings.
분석 기사 • Aug 31Estimating The Intrinsic Value Of Accentis N.V. (EBR:ACCB)How far off is Accentis N.V. ( EBR:ACCB ) from its intrinsic value? Using the most recent financial data, we'll take a...
Board Change • May 19Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Mieke De Clercq was the last independent director to join the board, commencing their role in 2015. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Feb 24Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: €0.013 (up from €0.005 in FY 2020). Revenue: €32.9m (up 64% from FY 2020). Net income: €17.0m (up 193% from FY 2020). Profit margin: 52% (up from 29% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 17% per year whereas the company’s share price has increased by 18% per year.
분석 기사 • Apr 08We Think Accentis (EBR:ACCB) Can Stay On Top Of Its DebtHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
분석 기사 • Mar 13Is Accentis N.V.'s (EBR:ACCB) Recent Stock Performance Influenced By Its Fundamentals In Any Way?Accentis' (EBR:ACCB) stock is up by a considerable 7.1% over the past month. We wonder if and what role the company's...
분석 기사 • Dec 27Accentis (EBR:ACCB) Has A Somewhat Strained Balance SheetSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
분석 기사 • Dec 06A Look At The Fair Value Of Accentis N.V. (EBR:ACCB)How far off is Accentis N.V. ( EBR:ACCB ) from its intrinsic value? Using the most recent financial data, we'll take a...
분석 기사 • Nov 17Is Accentis N.V.'s (EBR:ACCB) Recent Performance Tethered To Its Attractive Financial Prospects?Accentis' (EBR:ACCB) stock is up by 3.1% over the past month. Since the market usually pay for a company’s long-term...